| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |